Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) Director Richard W. Mott acquired 12,100 shares of the company’s stock in a transaction on Wednesday, May 22nd. The shares were acquired at an average cost of $4.99 per share, for a total transaction of $60,379.00. Following the completion of the acquisition, the director now owns […]
Advisory Research Inc. trimmed its position in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) by 58.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 46,844 shares of the company’s stock after selling 65,501 shares during the period. Advisory Research […]
Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) Director Richard W. Mott sold 4,043 shares of Treace Medical Concepts stock in a transaction dated Thursday, April 6th. The shares were sold at an average price of $26.00, for a total value of $105,118.00. Following the completion of the transaction, the director now owns 905,000 shares […]
Allspring Global Investments Holdings LLC increased its stake in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) by 278.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 478,815 shares of the company’s stock after buying an additional 352,208 shares during the period. Allspring Global […]
Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) Director Richard W. Mott sold 38,498 shares of Treace Medical Concepts stock in a transaction on Thursday, March 30th. The stock was sold at an average price of $26.00, for a total transaction of $1,000,948.00. Following the completion of the sale, the director now owns 1,020,000 shares […]